中国卒中杂志 ›› 2020, Vol. 15 ›› Issue (02): 167-168.DOI: 10.3969/j.issn.1673-5765.2020.02.011
• 文献导读 • 上一篇 下一篇
杨中华
出版日期:
发布日期:
通讯作者:
Online:
Published:
杨中华. Lancet N：卒中二级预防长期双联抗血小板的突破[J]. 中国卒中杂志, 2020, 15(02): 167-168.
YANG Zhong-Hua. Lancet N: A Breakthrough on Long-term Dual Antiplatelet Therapy for Stroke Secondary Prevention[J]. Chinese Journal of Stroke, 2020, 15(02): 167-168.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.chinastroke.org.cn/CN/10.3969/j.issn.1673-5765.2020.02.011
http://www.chinastroke.org.cn/CN/Y2020/V15/I02/167
TOYODA K，UCHIYAMA S，YAMAGUCHI T，et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan：a multicentre，open-label，randomised controlled trial[J]. Lancet Neurol，2019，18（6）：539-548.
